Healthy ageing is about maintaining energy, independence, and physical function as we get older. Rather than focusing only on lifespan, modern longevity science focuses on healthspan — the number of years lived in good health, mobility, and mental clarity.

In practical terms, healthy ageing means staying strong, capable, and independent for as long as possible.
This is where NMN (nicotinamide mononucleotide) has become a major focus in longevity and NAD⁺ research.

NMN is a naturally occurring compound in the body that plays a key role in cellular energy production.
It is a direct precursor to NAD⁺ (nicotinamide adenine dinucleotide), a coenzyme found in all cells that is essential for:
•   Energy metabolism
•   Mitochondrial function
•   DNA repair
•   Cellular repair and maintenance
As we age, NAD⁺ levels naturally decline, which is linked to reduced energy, slower recovery, and changes in metabolic health.

NAD⁺ levels decline gradually across the lifespan rather than suddenly.

Research shows NAD⁺ begins to decrease from early adulthood (around the 20s to early 30s), with a more noticeable decline occurring through the 40s and 50s (PMC7442590).

By midlife (40–60 years), NAD⁺ levels are significantly lower compared to younger adulthood. This continues into 60+ years, where reduced NAD⁺ availability is associated with:
•   Reduced mitochondrial efficiency
•   Lower cellular repair capacity
•   Decreased metabolic resilience
This age-related decline is a key reason NMN supplementation has gained interest in healthy ageing and longevity research.

NMN is being studied for its role in supporting NAD⁺ levels and cellular energy systems.

Early research suggests NMN may support:
•   Cellular energy production and vitality
•   Metabolic health and glucose regulation
•   Exercise performance and endurance
•   Healthy ageing pathways linked to mitochondrial function
While results are promising, human studies are still developing, and NMN is not classified as a treatment for disease.

Instead, NMN is considered a supportive compound for healthy ageing and cellular energy optimisation.

NMN is commonly used by people who notice gradual age-related changes such as:
•   Lower baseline energy levels
•   Slower recovery after exercise or stress
•   Reduced stamina or endurance
•   Feeling less resilient than in earlier adult years
•   Increased focus on maintaining independence and long-term health

It is also used by individuals already prioritising healthy ageing through exercise, nutrition, and sleep, who want additional support for cellular energy pathways.

One example in the NMN category is CellVive NMN®, developed by Longevity Life Sciences.

CellVive NMN® is a high-purity NMN ingredient used in regulated supplement formulations in Australia. It is manufactured using enzymatic synthesis and standardised for ≥99% purity, with strict quality control processes aligned with pharmaceutical-grade manufacturing standards.

It is also supplied within a regulated framework for listed medicines, supporting consistency, traceability, and ingredient reliability.

This reflects a broader trend in NMN supplements toward higher-quality, research-aligned raw materials rather than generic wellness formulations.

Even with growing interest in NMN and NAD⁺ support, the foundations of healthy ageing remain unchanged:
•   Regular resistance and aerobic exercise
•   Quality sleep and recovery
•   Nutrient-dense whole food diet
•   Stress management
•   Social connection and mental engagement

These factors remain the strongest predictors of long-term healthspan.
NMN is best viewed as a supportive addition to lifestyle, not a replacement.

Longevity science is shifting focus from simply extending lifespan to improving healthspan — living longer with independence, mobility, and cognitive function.

NMN is part of a growing area of research exploring how NAD⁺ decline influences ageing at a cellular level and how supporting these pathways may contribute to healthier ageing outcomes.

National Center for Biotechnology Information (2020) ‘NAD⁺ decline in ageing and metabolic regulation’, Experimental Gerontology, 139, 111021. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC7442590/ (Accessed: 13 May 2026).

National Center for Biotechnology Information (2022) ‘Nicotinamide mononucleotide (NMN) and NAD⁺ metabolism’, PMC. Available at: https://pmc.ncbi.nlm.nih.gov/articles/PMC9039735/ (Accessed: 13 May 2026).

Longevity Life Sciences (2025) CellVive NMN®. Available at: https://www.longevitylifesciences.com/cellvive-nmn/ (Accessed: 13 May 2026).
NMN.com (2024) What is NMN?. Available at: https://www.nmn.com/what-is-nmn (Accessed: 13 May 2026).